USB vs VXRT · P/E 12, rev $28.66B vs rev $28.7M
U.S. Bancorp (USB) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
USB currently screens at market cap $74.68B and trailing P/E 11.9. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the USB and VXRT stock pages for the full models.
Not investment advice.